购物车
- 全部删除
- 您的购物车当前为空
Nanterinone (UK 61260) 是一种口服的部分磷酸二酯酶抑制剂,是一种新型的正性肌力和平衡血管扩张化合物。Nanterinone 口服后,可使急性血流动力学得到明显改善,这可能取决于先前存在的左心室充盈压。
Nanterinone (UK 61260) 是一种口服的部分磷酸二酯酶抑制剂,是一种新型的正性肌力和平衡血管扩张化合物。Nanterinone 口服后,可使急性血流动力学得到明显改善,这可能取决于先前存在的左心室充盈压。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 998 | 现货 | |
5 mg | ¥ 2,490 | 现货 | |
10 mg | ¥ 3,720 | 现货 | |
25 mg | ¥ 5,990 | 现货 | |
50 mg | ¥ 8,290 | 现货 | |
100 mg | ¥ 10,900 | 现货 | |
500 mg | ¥ 22,300 | 现货 |
产品描述 | Nanterinone (UK 61260), an orally available partial phosphodiesterase inhibitor, is a novel positive inotropic and balanced vasodilator compound.Nanterinone, when administered orally, results in significant improvements in acute haemodynamics, which may depend on pre-existing left ventricular filling pressures.Nanterinone is a novel positive inotropic and balanced vasodilator that has demonstrated acute hemodynamic effects in patients with mild to moderate heart failure. |
体内活性 | Nanterinone(口服2 mg;适用于NYHA II-III级患者;ACE)能显著改善急性血液动力学,并且耐受性好。虽然左心室充盈压力的改变在基线PCWP较高的患者中更为明显,但心脏泵功能在基线左心室充盈压力正常或偏低的患者中同样得到改善。[1] |
别名 | UK-61260, UK61260, UK 61260 |
分子量 | 253.3 |
分子式 | C15H15N3O |
CAS No. | 102791-47-9 |
Smiles | CC=1N(C=C(C)N1)C=2C=C3C(=C(C)C2)NC(=O)C=C3 |
密度 | 1.24g/cm3 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度信息 | DMSO: Slightly soluble |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容